NASDAQ:BBIO

Bridgebio Pharma Stock Insider Trading

etoro logo Buy BBIO
*Your capital is at risk
$83.08
-2.81 (-3.27%)
At Close: Jul 13, 2026

Bridgebio Pharma Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -86.30. In total, the insiders bought 519.76K and sold 490.88K BBIO shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-86.30
Buy 519.76K shares
Sell 490.88K shares
44% Buy Activity
Moderate Negative Correlation
Buy Signal Low Confidence
Jun 22, 2026

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -86.3.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Jun 24, 2026
Sell
Common Stock
S-Sale
Cook Jennifer E.
Director
Director 37 167
Value: $2.60M
Jun 24, 2026
Buy
Stock Option (Right to Buy)
M-Exempt
Cook Jennifer E.
Director
Director 17 167
Value: $287.5K
Jun 24, 2026
Buy
Stock Option (Right to Buy)
M-Exempt
Cook Jennifer E.
Director
Director 20 000
Value: $169.0K
Jun 24, 2026
Buy
Common Stock
M-Exempt
Cook Jennifer E.
Director
Director 20 000
Value: $169.0K
Jun 24, 2026
Buy
Common Stock
M-Exempt
Cook Jennifer E.
Director
Director 17 167
Value: $287.5K
Jun 23, 2026
Sell
Common Stock
S-Sale
Valantine Hannah
Director
Director 2 196
Value: $150.6K
Jun 23, 2026
Sell
Common Stock
S-Sale
Cook Jennifer E.
Director
Director 2 196
Value: $150.6K
Jun 22, 2026
Buy
Stock Option (Right to Buy)
A-Award
Mccormick Frank
Director
Director 5 277
Value: $363.7K
Jun 22, 2026
Buy
Common Stock
A-Award
Mccormick Frank
Director
Director 3 990
Value: $275.0K
Jun 22, 2026
Buy
Stock Option (Right to Buy)
A-Award
Momtazee James C
Director
Director 5 277
Value: $363.7K
Jun 22, 2026
Sell
Common Stock
S-Sale
Valantine Hannah
Director
Director 2 808
Value: $190.9K
Jun 22, 2026
Buy
Common Stock
A-Award
Lo Andrew
Director
Director 3 990
Value: $275.0K
Jun 22, 2026
Buy
Stock Option (Right to Buy)
A-Award
Valantine Hannah
Director
Director 5 277
Value: $363.7K
Jun 22, 2026
Buy
Stock Option (Right to Buy)
M-Exempt
Valantine Hannah
Director
Director 2 808
Value: $117.2K
Jun 22, 2026
Buy
Stock Option (Right to Buy)
A-Award
Homcy Charles J
Director
Director 5 277
Value: $363.7K
Jun 22, 2026
Buy
Stock Option (Right to Buy)
A-Award
Aguiar Eric
Director
Director 5 277
Value: $363.7K
Jun 22, 2026
Buy
Common Stock
A-Award
Aguiar Eric
Director
Director 3 990
Value: $275.0K
Jun 22, 2026
Buy
Common Stock
A-Award
Dachille Douglas A.
Director
Director 3 990
Value: $275.0K
Jun 22, 2026
Buy
Stock Option (Right to Buy)
A-Award
Cook Jennifer E.
Director
Director 5 277
Value: $363.7K
Jun 22, 2026
Buy
Common Stock
M-Exempt
Valantine Hannah
Director
Director 2 808
Value: $117.2K
Jun 22, 2026
Buy
Common Stock
A-Award
Valantine Hannah
Director
Director 3 990
Value: $275.0K
Jun 22, 2026
Buy
Common Stock
A-Award
Daniels Ronald J
Director
Director 3 990
Value: $275.0K
Jun 22, 2026
Buy
Stock Option (Right to Buy)
A-Award
Lo Andrew
Director
Director 5 277
Value: $363.7K
Jun 22, 2026
Buy
Common Stock
A-Award
Homcy Charles J
Director
Director 3 990
Value: $275.0K
Jun 22, 2026
Buy
Stock Option (Right to Buy)
A-Award
Satvat Ali J.
Director
Director 5 277
Value: $363.7K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT BRIDGEBIO PHARMA INC.
Bridgebio Pharma
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabilizer of transthyretin, or TTR that is in Phase 3 clinical trial for the treatment of TTR amyloidosis-car...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
10.58% Jun 29
NMRK
$15.02
0.466% Jun 24
X
XMAX
$8.34
2.40% Jun 24
NESR
$25.07
12.49% Jun 23
CAG
$13.43
6.70% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE